<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Su R</submitter><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>HCC poses a significant global health burden, with HBV being the predominant etiology in China. However, current diagnostic markers lack the requisite sensitivity and specificity. This study aims to develop and validate serum N-glycomics-based models for the diagnosis and prognosis of HCC in patients with chronic hepatitis B-related cirrhosis.&lt;h4>Approach and results&lt;/h4>This study enrolled a total of 397 patients with chronic hepatitis B-related cirrhosis and HCC for clinical management. N-glycomics profiling was conducted on all participants, and clinical data were collected. First, machine learning-based models, Hepatocellular Carcinoma Glycomics Random Forest model and Hepatocellular Carcinoma Glycomics Support Vector Machine model, were established for earl</pubmed_abstract><journal>Hepatology (Baltimore, Md.)</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12700682</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Early screening, diagnosis and recurrence monitoring of hepatocellular carcinoma in patients with chronic hepatitis B based on serum N-glycomics analysis: A cohort study.</pubmed_title><pmcid>PMC12700682</pmcid><pubmed_authors>Xu L</pubmed_authors><pubmed_authors>Yan L</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Chen CC</pubmed_authors><pubmed_authors>Li P</pubmed_authors><pubmed_authors>Miao J</pubmed_authors><pubmed_authors>Kuai W</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Mi Y</pubmed_authors><pubmed_authors>Hou J</pubmed_authors><pubmed_authors>Su R</pubmed_authors><pubmed_authors>Tao X</pubmed_authors><pubmed_authors>Liu F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early screening, diagnosis and recurrence monitoring of hepatocellular carcinoma in patients with chronic hepatitis B based on serum N-glycomics analysis: A cohort study.</name><description>&lt;h4>Background and aims&lt;/h4>HCC poses a significant global health burden, with HBV being the predominant etiology in China. However, current diagnostic markers lack the requisite sensitivity and specificity. This study aims to develop and validate serum N-glycomics-based models for the diagnosis and prognosis of HCC in patients with chronic hepatitis B-related cirrhosis.&lt;h4>Approach and results&lt;/h4>This study enrolled a total of 397 patients with chronic hepatitis B-related cirrhosis and HCC for clinical management. N-glycomics profiling was conducted on all participants, and clinical data were collected. First, machine learning-based models, Hepatocellular Carcinoma Glycomics Random Forest model and Hepatocellular Carcinoma Glycomics Support Vector Machine model, were established for earl</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-06T02:03:25.932Z</modification><creation>2026-05-24T03:12:18.305Z</creation></dates><accession>S-EPMC12700682</accession><cross_references><pubmed>40117651</pubmed><doi>10.1097/HEP.0000000000001316</doi></cross_references></HashMap>